These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3493912)

  • 1. Opposite effects of a D1 and a D2 agonist on oral movements in rats.
    Johansson P; Levin E; Gunne L; Ellison G
    Eur J Pharmacol; 1987 Jan; 134(1):83-8. PubMed ID: 3493912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic neuroleptics alter the effects of the D1 agonist SK&F 38393 and the D2 agonist LY171555 on oral movements in rats.
    Ellison G; Johansson P; Levin E; See R; Gunne L
    Psychopharmacology (Berl); 1988; 96(2):253-7. PubMed ID: 2906749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diminished D2 dopamine receptor function and the emergence of repetitive jaw movements.
    Rosengarten H; Schweitzer JW; Egawa M; Friedhoff AJ
    Adv Exp Med Biol; 1988; 235():159-67. PubMed ID: 2976249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. D1 and D2 dopamine receptor interactions with pilocarpine-induced oral activity in rats.
    Levin ED; Ellison GD; See RE; South D; Young E
    Pharmacol Biochem Behav; 1989 Jul; 33(3):501-5. PubMed ID: 2573903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine D-1 receptor agonists combined with the selective D-2 agonist quinpirole facilitate the expression of oral stereotyped behaviour in rats.
    Arnt J; Hyttel J; Perregaard J
    Eur J Pharmacol; 1987 Jan; 133(2):137-45. PubMed ID: 2949991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioural effects of dopamine D-1 and D-2 receptor agonists in monkeys previously treated with haloperidol.
    Lublin H; Gerlach J
    Eur J Pharmacol; 1988 Aug; 153(2-3):239-45. PubMed ID: 3263277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic effects of D1 and D2 dopamine agonists on turning behaviour in rats.
    Robertson GS; Robertson HA
    Brain Res; 1986 Oct; 384(2):387-90. PubMed ID: 2946360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rotation following intranigral injections of a selective D1 or a selective D2 dopamine receptor agonist in rats.
    Asin KE; Montana WE
    Pharmacol Biochem Behav; 1988 Jan; 29(1):89-92. PubMed ID: 3258427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of oral dyskinesias in naive rats by D1 stimulation.
    Rosengarten H; Schweitzer JW; Friedhoff AJ
    Life Sci; 1983 Dec; 33(25):2479-82. PubMed ID: 6227782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional interaction between dopamine D1 and D2 receptors in rat jaw movements.
    Koshikawa N; Kikuchi de Beltrán K; Tomiyama K; Kobayashi M; Cools AR
    Eur J Pharmacol; 1991 Aug; 201(1):47-51. PubMed ID: 1838984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
    Weick BG; Walters JR
    Brain Res; 1987 Mar; 405(2):234-46. PubMed ID: 2952219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of dopamine D1 and D2 receptor antagonists on oral activity in rats.
    Levin ED; See RE; South D
    Pharmacol Biochem Behav; 1989 Sep; 34(1):43-8. PubMed ID: 2576312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological characterization of the receptor mediating electrophysiological responses to dopamine in the rat medial prefrontal cortex: a microiontophoretic study.
    Sesack SR; Bunney BS
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1323-33. PubMed ID: 2564893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective D1 and D2 receptor manipulation in Cebus monkeys: relevance for dystonia and dyskinesia in humans.
    Kistrup K; Gerlach J
    Pharmacol Toxicol; 1987 Sep; 61(3):157-61. PubMed ID: 2891133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of selective dopamine receptor agonists and antagonists on body temperature in rats.
    Faunt JE; Crocker AD
    Eur J Pharmacol; 1987 Jan; 133(3):243-7. PubMed ID: 2951265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation.
    Hess EJ; Albers LJ; Le H; Creese I
    J Pharmacol Exp Ther; 1986 Sep; 238(3):846-54. PubMed ID: 3018223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of stereotyped behavior and production of latent locomotor behaviors in mice treated continuously with quinpirole.
    Zhou LW; Qin ZH; Weiss B
    Neuropsychopharmacology; 1991 Jan; 4(1):47-55. PubMed ID: 1672250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective dopamine D2 receptor reduction enhances a D1-mediated oral dyskinesia in rats.
    Rosengarten H; Schweitzer JW; Friedhoff AJ
    Life Sci; 1986 Jul; 39(1):29-35. PubMed ID: 3523096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of selective D1 and D2 dopamine receptor antagonists and agonists in Cebus monkeys: implications for acute and tardive dyskinesias. A preliminary report.
    Gerlach J; Kistrup K; Korsgaard S
    Psychopharmacol Ser; 1987; 3():236-42. PubMed ID: 3547396
    [No Abstract]   [Full Text] [Related]  

  • 20. Prefrontal, accumbal [shell] and ventral striatal mechanisms in jaw movements and non-cyclase-coupled dopamine D1-like receptors.
    Adachi K; Hasegawa M; Fujita S; Lee J; Cools AR; Waddington JL; Koshikawa N
    Eur J Pharmacol; 2003 Jul; 473(1):47-54. PubMed ID: 12877937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.